Related references
Note: Only part of the references are listed.Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
Celine Kaegi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
Hattie Hanna Dolin et al.
CLINICAL CASE REPORTS (2019)
Frontline therapies for untreated chronic lymphoid leukemia
Delong Liu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults
Alexandra Serris et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)
Marc Michel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
Haifei Chen et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
Sigbjorn Berentsen et al.
BLOOD (2017)
Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study
Stephane Ducassou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study
Ygal Benhamou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA
Kamel Laribi et al.
ANNALS OF HEMATOLOGY (2016)
A monocentric retrospective study comparing pulse cyclophosphamide therapy versus low dose rituximab in the treatment of refractory autoimmune hemolytic anemia in adults
Rong Fu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Atypical hemolytic uremic syndrome secondary to lupus nephritis, responsive to eculizumab
Alexander G. Raufi et al.
HEMATOLOGY REPORTS (2016)
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)
Anne Quinquenel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies
Quitterie Reynaud et al.
AUTOIMMUNITY REVIEWS (2015)
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab
William F. Clark et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Immune Hemolysis: Diagnosis and Treatment Recommendations
Wilma Barcellini
SEMINARS IN HEMATOLOGY (2015)
Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy
Sigbjorn Berentsen et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome
Priyanka Khandelwal et al.
PEDIATRIC NEPHROLOGY (2015)
Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases
Halima El Omri et al.
CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS (2015)
Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients
Mathilde Roumier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: Diagnosis and classification
Boris Shenkman et al.
AUTOIMMUNITY REVIEWS (2014)
Diagnosis and classification of autoimmune hemolytic anemia
Garrett F. Bass et al.
AUTOIMMUNITY REVIEWS (2014)
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
Miguel Hie et al.
BLOOD (2014)
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini et al.
BLOOD (2014)
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
Henrik Birgens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia
Su W. Maung et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia
Wilma Barcellini et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse
J-P. Westwood et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini et al.
BLOOD (2012)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Antoine Froissart et al.
CRITICAL CARE MEDICINE (2012)
Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia
J. Rossignol et al.
LEUKEMIA (2011)
Classification and therapeutic approaches in autoimmune hemolytic anemia: an update
Marc Michel
EXPERT REVIEW OF HEMATOLOGY (2011)
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia
Francisco Javier Penalver et al.
ANNALS OF HEMATOLOGY (2010)
Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
Jens Marcus Chemnitz et al.
ANNALS OF HEMATOLOGY (2010)
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Sigbjorn Berentsen et al.
BLOOD (2010)
Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom
C. Mark Taylor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study
Javier de la Rubia et al.
TRANSFUSION AND APHERESIS SCIENCE (2010)
Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: A report of 13 cases and review of the literature
Huichung T. Ling et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases
Guillaume Bussone et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases
Marc Michel et al.
BLOOD (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Autoimmune hemolytic anemia
D. Dierickx et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Rituximab as an Adjunct to Plasma Exchange in TTP: A Report of 12 Cases and Review of Literature
Sushama Jasti et al.
JOURNAL OF CLINICAL APHERESIS (2008)
Rituximab therapy for childhood Evans syndrome
Brigitte Bader-Meunier et al.
HAEMATOLOGICA (2007)
Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients
Giovanni D'Arena et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Rituximab in chronic cold agglutinin disease:: a prospective study of 20 patients
C Schöllkopf et al.
LEUKEMIA & LYMPHOMA (2006)
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases
F Fakhouri et al.
BLOOD (2005)
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
S Berentsen et al.
BLOOD (2004)
Methodological index for non-randomized studies (MINORS):: Development and validation of a new instrument
K Slim et al.
ANZ JOURNAL OF SURGERY (2003)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
